ArticlePharmaceutical statistics
Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application.
Article in Pharmaceutical statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application.Pharmaceutical statisticsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overdispersion, a common issue in clustered multinomial data, can lead to biased standard errors and compromised statistical inference if not adequately addressed. This study describes a comprehensive procedure for constructing multiple comparisons of interest and applying multiplicity adjustments in the analysis of clustered, potentially overdispersed multinomial data. We investigate four quasi-likelihood estimators and the Dirichlet-multinomial model to account for overdispersion. Through a simulation study, we evaluate the performance of these methods under various scenarios, focusing on family-wise error rate, statistical power and coverage probability. Our findings indicate that the Afroz quasi-likelihood estimator is recommended when strict error control is required, whereas the Dirichlet-multinomial model is preferable when high statistical power is desired, albeit with a slightly increased tolerance for false positives. Additionally, we address the challenge of zero-count categories within groups, demonstrating that incorporating pseudo-observations can effectively mitigate associated estimation difficulties. Practical applications to real datasets from toxicology and flow cytometry underscore the robustness and practical utility of these methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.